Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication

Soha M. Abd El Dayem; Abo El Magd El Bohy; Ahmed A. Battah; Mona Hamed; Shereen Hamdy Abd El Aziz

doi:10.3889/oamjms.2019.613

Authors

Soha M. Abd El Dayem Pediatrics Department, National Research Centre, Cairo, Egypt
Abo El Magd El Bohy Radiology Department, Cairo University, Cairo, Egypt
Ahmed A. Battah Critical Care Department, Cairo University, Cairo, Egypt
Mona Hamed Clinical Pathology Department, National Research Centre, Cairo, Egypt
Shereen Hamdy Abd El Aziz Clinical Pathology Department, National Research Centre, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2019.613

Keywords:

Osteopontin (OPN), type 1 diabetic patients, Carotid Dopplar

Abstract

AIM: To evaluate the relationship between osteopontin and diabetes complication in type 1 diabetic patient.

PATIENTS AND METHODS: Seventy types 1 diabetic and 60 healthy volunteers were studied. Full history, examination, laboratory tests of glycosylated haemoglobin (HbA1c), serum lipids {cholesterol, triglyceride (Tg), high-density lipoprotein-cholesterol (HDL-c), low-density lipoprotein â€“ cholesterol (LDL-c)}, oxidised low-density lipoprotein (OxLDL), Osteopontin and urinary microalbuminuria (albumin/creatinine ratio) were done. Image study in the form of a carotid intimal medial thickness (cIMT) and aortic intimal medial thickness (aIMT), renal doppler for resistivity index was also done for all participant included in the study.

RESULTS: Urinary albumin/creatinine ratio, lipid profile, osteopontin, cIMT and aIMT were higher in people with diabetes. Osteopontin was higher in people with diabetes with positive microalbuminuria and cIMT. Systolic blood pressure, microalbuminuria and cIMT had a positive correlation with osteopontin in people with diabetes. Stepwise multiple regression analysis showed that osteopontin had a significant correlation with cIMT. Receiver operating characteristic (ROC) curve showed that the cut off value of Osteopontin for detection of cIMT was > 60 with a specificity of 100% and sensitivity 80.5%, while that of albumin/creatinine ratio was > 64 with a specificity of 66.7 and sensitivity of 92.3.

CONCLUSION: Osteopontin is higher in type 1 diabetics and is useful for early detection of diabetic microvascular and macrovascular complication.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Sase SP, Genu JV, Nagane N. Osteopontin: a novel protein molecule. Ind Med Gaz. 2012; 62-66.

Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 2007; 27:2302-2309. https://doi.org/10.1161/ATVBAHA.107.144824 PMid:17717292

Kahles F, Findeisen HM, Bruemmer D. Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab. 2014; 3:384-393. https://doi.org/10.1016/j.molmet.2014.03.004 PMid:24944898 PMCid:PMC4060362

Hirota S, Imakita M, Kohri K, et al. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol. 1993; 143:1003-1008.

Berezin AE, Kremzer AA. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis. 2013; 229:475-481. https://doi.org/10.1016/j.atherosclerosis.2013.06.003 PMid:23880208

Kase S, Yokoi M, Saito W, et al. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res. 2007; 39:143-147. https://doi.org/10.1159/000102936 PMid:17505146

Yamaguchi H, Igarashi M, Hirata A, et al. Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. Endocr J. 2004; 51:499-504. https://doi.org/10.1507/endocrj.51.499 PMid:15516785

Abd El Dayem SM, El Bohy AEM, Battah AA. Carotid intimal medial thickness and its relation to endothelial dysfunction and echocardiographic changes in adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2015; 28(9-10):1029-1037. https://doi.org/10.1515/jpem-2014-0355

Abd El Dayem SM, Battah AA, El Bohy AEM, Yousef RN, Ahmed AM, Talaat AA. Apelin, Nitric Oxide and Vascular Affection in Adolescent Type 1 Diabetic Patients. Open Access Maced J Med Sci. 2017; 5(7):934-939. https://doi.org/10.3889/oamjms.2017.204 PMid:29362622 PMCid:PMC5771298

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972; 18:499-02.

Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 2003; 41:661-665. https://doi.org/10.1016/S0735-1097(02)02894-2

El Dayem SM, Battah AA, El Bohy AE. Assessment of Increase in Aortic and Carotid Intimal Medial Thickness in Type 1 Diabetic Patients. Open Access Maced J Med Sci. 2016; 4(4):630-635. https://doi.org/10.3889/oamjms.2016.118 PMid:28028403 PMCid:PMC5175511

El Dayem SM, El Bohy AE, Battah AA. Carotid intimal medial thickness and its relation to endothelial dysfunction and echocardiographic changes in adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2015; 28(9-10):1029-1037. https://doi.org/10.1515/jpem-2014-0355

McGill HC, McMahan CA, Herderick EE, et al. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery: PDAY research group: Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 2000; 20:836-845. https://doi.org/10.1161/01.ATV.20.3.836 PMid:10712411

Abd El Dayem SM, Battah AA, Bohy E, El Magd A, Hamed M, Habib SA. Nesfatin level is an early indicator of atherosclerosis in type 1 diabetic patients. Bioscience Research. 2018; 15(4):4079-4086.

Saif A, Soliman NA, Abdel-Hamed A. Early evaluation of renal hemodynamic alterations in type I diabetes mellitus with duplex ultrasound. Saudi J Kidney Dis Transpl. 2010; 21:295-9.

El Dayem SA, El magd El Bohy A, El Shehaby A. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients. J Pediatr Endocrinol Metab. 2016; 29(3):273-9. https://doi.org/10.1515/jpem-2014-0397 PMid:26677884

Noushin, Kiavash F, Elham HD, Mahdieh O. Association between Vascular Endothelial Markers and Carotid Intima-Media Thickness in Children and Adolescents with Type 1 Diabetes Mellitus. Journal of Clinical and Diagnostic Research. 2017; 11(9):SC01-SC05.

Elâ€Asrar MA, Ismail EA, Thabet R, Kamel A, NehmedAllah S. Osteopontin as a marker of vasculopathy in pediatric patients with type 1 diabetes mellitus. Pediatric Diabetes. 2018; 19(6):1107-15. https://doi.org/10.1111/pedi.12686 PMid:29687557

El-Asrar MA, Elbarbary NS, Ismail EA, Bakr AA. Circulatingangiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness. Angiogenesis. 2016; 19:421-431. https://doi.org/10.1007/s10456-016-9517-6 PMid:27236773

Gordin D, Forsblom C, Panduru NM, et al. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all cause mortality in patients with type 1 diabetes. Diabetes Care. 2014; 37:2593-2600. https://doi.org/10.2337/dc14-0065 PMid:24969575

Yan X, Sano M, Lu L, et al. Plasma concentrations of osteopontin, butnot thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2010; 9:70. https://doi.org/10.1186/1475-2840-9-70 PMid:21034455 PMCid:PMC2988001